Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
A single 300,000 IU dose of vitamin D, often called stoss or megadose therapy, is generally reserved for severe deficiency, rickets, osteomalacia, malabsorption, or patients unlikely to take daily supplements, because it can restore blood levels in days instead of months. Clinicians weigh baseline 25(OH)D results, calcium and kidney status, and conditions such as sarcoidosis or hyperparathyroidism before choosing rapid repletion, and doses this large are not intended for routine maintenance. There are several important safety, monitoring, and dosing-interval factors to consider, so see below to understand more.
If fatigue, bone or muscle pain, weakness, or frequent illness has you wondering whether defic
Vitamin D plays a critical role in bone health, immune function and muscle strength. In certain cases—especially pediatric rickets or severe deficiency—doctors may choose a one-time “megadose” of vitamin D, often referred to as Stoss therapy. This approach uses a single high dose, such as 300,000 IU, to restore vitamin D levels quickly. Below, we outline the rationale, evidence, benefits, risks and practical considerations of this treatment.
Several clinical studies and guidelines support single high-dose therapy:
While generally safe, single megadoses carry some risks:
Mitigation strategies:
| Feature | Single 300,000 IU Dose | Daily/Weekly Dosing |
|---|---|---|
| Convenience | One-time administration | Ongoing compliance required |
| Time to Replete Stores | 4–6 weeks | 8–12 weeks |
| Monitoring Needs | Baseline + 1–2 follow-ups | Regular follow-up at 3-month intervals |
| Risk of Missed Doses | Minimal | Higher if adherence is poor |
| Flexibility | Low (fixed dose) | High (dose can be adjusted frequently) |
After a one-time 300,000 IU dose, transition to a maintenance regimen:
Regularly check:
If you or your child experiences any of the following after megadose therapy, contact a healthcare professional promptly:
For non-emergency concerns or to explore symptoms further, you can do a free, online symptom check, using the doctor approved Ubie Symptom Checker.
If you suspect severe vitamin D deficiency, rickets or have unexplained bone pain and muscle weakness, speak to a doctor. Reliable evaluation and personalized dosing are essential to safe, effective treatment.
(References)
* Delafuente JC. Nutrients and immune responses. Rheum Dis Clin North Am. 1991 May;17(2):203-12. PMID: 1907394.
* Koçyiğit C, Çatlı G, İnce G, Özkan EB, Dündar BN. Can Stoss Therapy Be Used in Children with Vitamin D Deficiency or Insufficiency without Rickets? J Clin Res Pediatr Endocrinol. 2017 Jun 1;9(2):150-155. doi: 10.4274/jcrpe.3842. Epub 2017 Jan 12. PMID: 28077342; PMCID: PMC5463288.
* Tannous P, Fiscaletti M, Wood N, Gunasekera H, Zurynski Y, Biggin A, Kilo T, Hayes E, Munns C. Safety and effectiveness of stoss therapy in children with vitamin D deficiency. J Paediatr Child Health. 2020 Jan;56(1):81-89. doi: 10.1111/jpc.14497. Epub 2019 May 28. PMID: 31136042.
* Barkun AN, Almadi M, Kuipers EJ, Laine L, Sung J, Tse F, Leontiadis GI, Abraham NS, Calvet X, Chan FKL, Douketis J, Enns R, Gralnek IM, Jairath V, Jensen D, Lau J, Lip GYH, Loffroy R, Maluf-Filho F, Meltzer AC, Reddy N, Saltzman JR, Marshall JK, Bardou M. Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group. Ann Intern Med. 2019 Dec 3;171(11):805-822. doi: 10.7326/M19-1795. Epub 2019 Oct 22. PMID: 31634917; PMCID: PMC7233308.
* Henderson SW. A Case of Clinical Scholarship. J Am Acad Child Adolesc Psychiatry. 2020 May;59(5):583-585. doi: 10.1016/j.jaac.2019.09.029. PMID: 32340688.
* Ataide FL, Carvalho Bastos LM, Vicente Matias MF, Skare TL, Freire de Carvalho J. Safety and effectiveness of vitamin D mega-dose: A systematic review. Clin Nutr ESPEN. 2021 Dec;46:115-120. doi: 10.1016/j.clnesp.2021.09.010. Epub 2021 Sep 25. PMID: 34857184.
* De Benedetti F, Grom AA, Brogan PA, Bracaglia C, Pardeo M, Marucci G, Eleftheriou D, Papadopoulou C, Schulert GS, Quartier P, Antón J, Laveille C, Frederiksen R, Asnaghi V, Ballabio M, Jacqmin P, de Min C. Efficacy and safety of emapalumab in macrophage activation syndrome. Ann Rheum Dis. 2023 Jun;82(6):857-865. doi: 10.1136/ard-2022-223739. Epub 2023 Mar 31. PMID: 37001971; PMCID: PMC10314091.
* Meschiari M, Asquier-Khati A, Tiseo G, Luque-Paz D, Murri R, Boutoille D, Falcone M, Mussini C, Tattevin P, Italian Society of Infectious and Tropical Diseases (SIMIT), and the French Society of Infectious Diseases (SPILF). Treatment of infections caused by multidrug-resistant Gram-negative bacilli: A practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases. Int J Antimicrob Agents. 2024 Jul;64(1):107186. doi: 10.1016/j.ijantimicag.2024.107186. Epub 2024 Apr 28. PMID: 38688353.
* Hang Kong AY, Tan HS, Habib AS. VX-548 in the treatment of acute pain. Pain Manag. 2024 Sep;14(9):477-486. doi: 10.1080/17581869.2024.2421749. Epub 2024 Nov 18. PMID: 39552600; PMCID: PMC11721852.
* Finkel RS, Crawford TO, Mercuri E, Sumner CJ, Garcia Romero MDM, Day JW, Montes J, Sun P, Tichler B, Paradis AD, Boesch E, Inra J, Littauer R, Sohn J, Monine M, Gambino G, Foster R, Farewell R, Fradette S. High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial. Nat Med. 2026 Mar;32(3):1095-1104. doi: 10.1038/s41591-025-04193-6. Epub 2026 Feb 3. PMID: 41634391; PMCID: PMC13004686.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.